Hook / Thesis
Array Technologies (ARRY) is cheap on near-term metrics and positioned to benefit from a product-driven rebound in 2027. The company announced a 60-degree DuraTrack variant on 07/22/2026 designed to reduce hail risk and lower project CAPEX while coupling with SmarTrack software and Hail Alert Response. That product won't meaningfully ship until mid-2027, but the commercial availability window and existing balance-sheet strength give investors a tangible catalyst to aim at.
From a capital-allocation and valuation angle, the setup is straightforward: market cap sits around $745M, enterprise value roughly $1.09B, and reported free cash flow was $134.7M. That FCF generation gives ARRY a rare margin of safety for a small-cap industrial name: FCF yield on enterprise value is high, and the company can fund go-to-market investments for new variants without immediate equity dilution. I’m constructive: take a long position sized to your risk tolerance, target a move back toward a mid-single-digit to low-teens multiple as execution and 2027 deliveries materialize.
What the company does - and why the market should care
Array manufactures ground-mount solar trackers (DuraTrack and SmarTrack) used by EPCs, developers, IPPs and utilities. Ground-mounted tracking remains the dominant segment of PV mounting systems; a recent market estimate put global Solar PV Mounting Systems at $45.45B in 2025, growing to $70.64B by 2035 at a ~4.5% CAGR. That is a structural backdrop where a differentiated tracker that addresses extreme weather - hail, for instance - can win incremental share or higher-margin projects.
Practical importance: large utility projects care about levelized cost of energy (LCOE) and project risk. A 60-degree stow solution that reduces hail exposure while lowering CAPEX and using AC grid-powered motors can materially change project economics in hail-prone regions and tilt procurement decisions toward Array on bid lists for 2027 builds.
Numbers that matter
- Current price near $4.84, market cap roughly $745M and enterprise value about $1.09B.
- Free cash flow for the most recent period: $134,728,000 — this delivers a healthy FCF yield versus enterprise value (~12% FCF/EV by rough math).
- Price-to-sales ~0.62 and EV-to-sales ~0.92, implying the market is pricing modest top-line expectations.
- Negative EPS (-$0.96) and negative P/E reflect the company’s recent profitability swings, but cash metrics and low price-to-cash-flow (4.54) / price-to-FCF (5.49) indicate operational cash generation despite GAAP losses.
- Balance sheet and liquidity ratios: current ratio ~2.2 and quick ratio ~1.81 — adequate short-term liquidity to execute on product ramp and support sales cycles heading into 2027.
- Short interest is elevated: ~32.0M shares as of 07/31/2026, which is roughly 21% of the float (float ~151.68M). That amplifies volatility but also creates a potential squeeze dynamic if sentiment turns positive around product wins or bookings.
Valuation framing
At ~ $745M market cap and enterprise value near $1.09B, Array trades at attractive cash-based multiples: price-to-cash-flow ~4.5x and price-to-free-cash-flow ~5.5x. EV/sales of ~0.92 implies the market expects subdued revenue growth or margin pressure relative to long-term potential. Given positive free cash flow of $134.7M, an investor paying $1.09B EV is effectively buying a meaningful FCF stream at a single-digit implied FCF multiple today.
Put another way: the market is valuing ARRY more like a cyclical commodity supplier than a differentiated technology player. If Array can translate the 60-degree tracker into higher win rates on larger projects or premium pricing (better economics for developers), multiples should re-rate higher toward peers or historical highs. A move back toward $8.50 implies modest multiple expansion and revenue/EBITDA recovery; a return to the 52-week high ($12.23) would require outsized execution and broader sentiment improvements in the sector.
Catalysts (what to watch)
- Commercial quotes and early order activity for the 60-degree DuraTrack (quotes available in 2026; deliveries expected mid-2027) - the first visible sales or awarded projects would be a material positive.
- Q3/Q4 2026 booking trends and backlog disclosure - improving bookings into year-end would signal demand pull-through ahead of mid-2027 deliveries.
- Margin expansion tied to manufacturing efficiency or higher content per MW via SmarTrack software - evidence of improving gross margin trajectory.
- Large EPC or utility level frame contracts or master supply agreements - any multi-year procurement deal would derisk revenue visibility and be a re-rating event.
- Sector sentiment: broader improvement in utility-scale solar procurement in North America and hail-prone geographies adopting hail-mitigation solutions.
Trade plan - actionable and precise
Primary trade (long):
- Entry price: $4.80 (enter size depending on risk tolerance).
- Stop loss: $3.80 (technical stop below recent support; protects against a structural downside break).
- Target price: $8.50 (target to be realized over time as the 60-degree variant drives orders and multiples re-rate).
- Time horizon: long term (180 trading days) - rationale: product is available for quotes in 2026 with deliveries expected mid-2027; meaningful revenue and margin improvement should surface within 46-180 trading days as pipeline converts.
Position sizing: cap position to what you can afford to hold through potential volatility given high short interest and cyclical demand. This is not a scalp. Expect swings: short covering, quarter-to-quarter booking noise, and sector sentiment can produce 20-40% intraday moves.
Technical backdrop
Technicals show the stock is nearer the 52-week low ($4.74) than the high ($12.23). Short-term moving averages are above the current price (10-day ~$5.15, 20-day ~$5.27, 50-day ~$6.32), and RSI sits around 36 - a mild oversold reading. MACD shows a small bullish histogram, which suggests momentum may stabilize even before fundamentals turn. The elevated short interest (~21% of float) will amplify both upside on positive news and downside on execution misses.
Risks and counterarguments
- Cyclical demand risk. Utility-scale solar procurement can be lumpy and driven by policy/tender timing. If project awarding slows or developers delay builds, revenue can disappoint versus market expectations.
- Execution risk on new product. The 60-degree variant needs to prove field reliability and cost advantages at scale; any installation issues or higher-than-expected warranty costs would hit margins and sentiment.
- Competitive pressure. Larger competitors and specialized tracker makers could match hail mitigation features or undercut pricing on large bids, compressing Array’s potential premium.
- Volatility from short interest. Elevated short positioning (~32M shares) means earnings misses or guide-downs can produce fast, deep selloffs; conversely, any positive surprise can spike the stock sharply, complicating stop management.
- Macro risk / capital markets. Higher rates or tightening project financing could slow utility-scale project starts and reduce near-term orders.
Counterargument to the bullish thesis: Even with a promising product and healthy cash flow, Array could remain range-bound if the market continues to prize scale and end-to-end energy platforms (inverters, storage integration), which favor larger players. If the market assigns a persistent discount to standalone tracker vendors, multiples may not expand materially despite improved product wins.
What would change my mind
I’d become materially less constructive if any of the following occur:
- Q3/Q4 bookings show no uptake of the 60-degree variant and backlog declines sequentially.
- Free cash flow turns negative or drops substantially (suggesting inventory build or margin stress beyond normal seasonality).
- Large-scale warranty or reliability issues surface in field deployments tied to the new product.
- Competitive pricing pressure forces sustained margin compression without offsetting volume gains.
Conclusion
Array Technologies is a measured long into 2027. The key facts that make the trade attractive are: an explicit product catalyst with commercial timelines (60-degree tracker), a low market valuation relative to cash-based metrics, and healthy free cash flow that gives the company optionality. The trade is not without risk — execution and sector cyclicality matter — but the risk/reward is appealing if you target the mid-2027 product-cycle inflection and manage downside with a disciplined stop.
If you buy, use the plan above, monitor early commercial wins and backlog closely, and be ready to trim into any near-term pop driven by short-covering. If product adoption lags or FCF deteriorates, exit and reassess.